All Stories

  1. Brexanolone (Zulresso): Finally, an FDA-Approved Treatment for Postpartum Depression

    Article • Annals of Pharmacotherapy, September 2019, SAGE Publications

    Jason Powell

  2. Andexanet alfa: A Novel Factor Xa Inhibitor Reversal Agent

    Article • Annals of Pharmacotherapy, February 2019, SAGE Publications

    Jason Powell

  3. Ertugliflozin: A New Option in the SGLT-2 Inhibitor Market for the Treatment of Type 2 Diabetes Mellitus

    Article • Annals of Pharmacotherapy, December 2018, SAGE Publications

    Jason Powell

  4. Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia

    Article • Diabetes Metabolic Syndrome and Obesity, March 2014, Taylor & Francis

    Jason Powell